Given the importance of JAK/STAT signaling in T-ALL30,31 and therapy resistance,32 we hypothesized that enhanced activity of this pathway might underlie the increased pathogenesis of Dnmt3a-mutant T-ALL. The gene discussed is DNMT3A; the disease is acute lymphoblastic leukemia.